OncoTargets and Therapy Journal Citation Rate 2026
1178-6930
Dove Medical Press
NZ
Q2 Quartile Open Access
About OncoTargets and Therapy
OncoTargets and Therapy (OT) is a peer-reviewed academic journal covering Cancer-related molecular mechanisms research and Circular RNAs in diseases, published by Dove Medical Press in NZ, catalogued under ISSN 1178-6930. As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 1.68 (Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access, with an Article Processing Charge (APC) of approximately $2836 USD. OpenAlex records 6,819 works and 157,330 citations, with an h-index of 113.
OncoTargets and Therapy Citation Rate 2026 — In Context
OncoTargets and Therapy has a 2025 2-Year Citation Rate (OpenAlex) of 1.68, placing it in the Q2 quartile within the Cancer-related molecular mechanisms research research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
As a fully open-access publication, OncoTargets and Therapy makes all articles freely available to readers for an Article Processing Charge of approximately $2836 USD.
Researchers looking to publish in OncoTargets and Therapy should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare OncoTargets and Therapy against similar journals in the field, use our journal comparison tool.
Submission Tips for OncoTargets and Therapy
- Budget $2836 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers Cancer-related molecular mechanisms research, Circular RNAs in diseases, Ferroptosis and cancer prognosis. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How OncoTargets and Therapy Compares
Compared against 50 journals in the same research areas.
| ISSN (Print) | 1178-6930 |
|---|---|
| Publisher | Dove Medical Press |
| Country | New Zealand |
| APC / Cost | $2836 USD |
| h-index | 113 |
| Total Works | 6,777 |
| Total Citations | 158,183 |
| 2-yr Mean Citedness | 2.13 (OpenAlex) |
In-depth profile & metrics
OncoTargets and Therapy is published by Dove Medical Press and based in New Zealand. It publishes open access with an article-processing charge of USD 2836.
In our subject taxonomy, OncoTargets and Therapy is classified under Cancer-related molecular mechanisms research, Circular RNAs in diseases, Ferroptosis and cancer prognosis and Lung Cancer Treatments and Mutations.
OncoTargets and Therapy is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
OpenAlex records 6,777 works that have together drawn 158,183 citations, giving the journal an h-index of 113; its most recent citation rate stands at 1.677; OpenAlex puts its two-year mean citedness at 2.13.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about OncoTargets and Therapy
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 1.677 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Works Published per Year (2014–2025)
Annual publication volume sourced from OpenAlex. Current year omitted (partial data).
Publication & citation history by year
| Year | Works published | Citations received |
|---|---|---|
| 2025 | 104 | 287 |
| 2024 | 142 | 394 |
| 2023 | 146 | 627 |
| 2022 | 191 | 1,595 |
| 2021 | 532 | 7,293 |
| 2020 | 1,174 | 26,930 |
| 2019 | 1,029 | 26,618 |
| 2018 | 901 | 25,772 |
| 2017 | 615 | 17,626 |
| 2016 | 803 | 21,270 |
| 2015 | 452 | 11,138 |
| 2014 | 259 | 7,946 |
Journal at a Glance
Source: OpenAlex — refreshed daily.
Top Research Topics
The areas where OncoTargets and Therapy most frequently publishes, ranked by article volume. Click a topic to see the best journals for it.
Compare Journals
Compare OncoTargets and Therapy against similar publications in its field:
Related Journals in Your Field
-
Cell Death and Disease Springer Nature IF 64.50
-
DNA and Cell Biology Mary Ann Liebert IF 64.50
-
Frontiers in Cell and Developmental Biology Frontiers Media SA IF 64.50
-
Cancer Cell International Springer Nature IF 64.50
-
Cell Biology International Wiley IF 64.50
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S120324992
Get weekly updates for Cancer-related molecular mechanisms research journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.